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Human infections with nontyphoidal Salmonella serotypes, such as S. enterica serotype Typhimurium, are
characterized by a massive neutrophil influx in the colon and terminal ileum. In contrast, neutrophils are
scarce in intestinal infiltrates of typhoid fever patients. Here, we show that in S. enterica serotype Typhi, the
causative agent of typhoid fever, expression of the Vi capsular antigen reduced expression of the neutrophil
chemoattractant interleukin-8 (IL-8) in host cells. Capsulated bacteria elicited IL-8 expression in polarized
human epithelial cells (T84) and human macrophage-like cells (THP-1) in vitro at significantly reduced levels
compared to noncapsulated bacteria. Experiments with a human cell line (HEK293) transfected with human
Toll-like receptors (TLRs) demonstrated that in the presence of TLR5 or TLR4/MD2/CD14, a noncapsulated
serotype Typhi mutant was able to induce the expression of IL-8, while this host response was significantly
reduced when cells were infected with the capsulated serotype Typhi wild type. The relevance of these in vitro
observations for the interaction of serotype Typhi with its human host was further studied ex vivo using human
colonic tissue explants. Expression of IL-8 was detected in human colonic tissue explants infected with serotype
Typhimurium or a noncapsulated serotype Typhi mutant. In contrast, infection with the serotype Typhi wild
type did not elicit IL-8 expression in colonic tissue explants. Collectively, these data suggest that the scarcity
of neutrophils in intestinal infiltrates of typhoid fever patients is due to a capsule-mediated reduction of
TLR-dependent IL-8 production in the intestinal mucosa.
Salmonella enterica serotype Typhi is a strictly human-
adapted pathogen responsible for some 600,000 deaths and
16,000,000 cases of typhoid fever annually (20). The type of
inflammatory infiltrate elicited in the intestines of typhoid fe-
ver patients is strikingly different from that observed in pa-
tients infected with nontyphoidal Salmonella serotypes, such as
S. enterica serotype Typhimurium. Serotype Typhimurium in-
fections in humans are characterized by a massive neutrophil
influx in the terminal ileum and proximal colon (4, 19) and the
predominance of neutrophils in stool samples (9). Experiments
with cultured human epithelial cells and macrophages suggest
that this neutrophil influx is triggered because pathogen-asso-
ciated molecular patterns (PAMPs) of serotype Typhimurium
activate Toll-like receptor (TLR) signaling pathways, thereby
resulting in the release of neutrophil chemoattractants (e.g.,
interleukin-8 [IL-8]) (22, 23, 27, 36). In contrast, serotype
Typhi does not elicit a massive neutrophil influx in the human
intestine. Instead, mononuclear cells are the predominant cell
type identified in intestinal infiltrates (17, 21, 24, 32) and in
stool samples of typhoid fever patients (9).
Microarray analysis shows that serotype Typhimurium and
purified serotype Typhimurium flagella trigger a classical
proinflammatory gene expression program in human colonic
carcinoma cells that depends on the recognition of flagella
through TLR5 (36). In contrast, serotype Typhi does not trig-
ger this proinflammatory expression profile in human colonic
carcinoma cells (36) despite the fact that purified serotype
Typhi flagella are potent inducers of proinflammatory cytokine
secretion in human monocytes (34, 35). These observations
raise the possibility that, unlike serotype Typhimurium, sero-
type Typhi expresses factors during intestinal invasion that
allow it to down-regulate a TLR-mediated host response that
leads to neutrophil infiltration. Furthermore, since the mech-
anism underlying innate immune evasion by serotype Typhi is
not operational in serotype Typhimurium, it is likely encoded
by a serotype Typhi DNA region that is absent from the sero-
type Typhimurium genome.
Whole genome sequencing has revealed that serotype Typhi
strain CT18 possesses 601 genes present on 82 genetic islands
that are absent from the serotype Typhimurium LT-2 chromo-
some (25). The largest of these genetic islands is a 134-kb DNA
region, termed Salmonella pathogenicity island 7 (SPI7). A
region within SPI7, termed the viaB locus, contains genes re-
quired for the biosynthesis and the export of the Vi capsular
antigen, a linear polymer of -1,4(2-deoxy)-2-N-acetylgalactu-
ronic acid variably O-acetylated at the C3 position (10). This
capsular polysaccharide is expressed in vitro in macrophages
(3) and during human infection, as indicated by protection
against typhoid fever following vaccination with the Vi antigen
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(16). The Vi antigen has recently been implicated in preventing
IL-8 production in human macrophage-like cells (THP-1) (11)
and in human colonic carcinoma cells (Caco-2) (31). The Vi
antigen is thus a promising candidate for a serotype Typhi-
specific virulence factor that blocks the TLR-mediated host
responses leading to neutrophil infiltration. Here, we tested
this hypothesis using human tissue culture models.
Studies on the pathogenesis of typhoid fever are compli-
cated by the fact that serotype Typhi is a strictly human-
adapted pathogen. Serotype Typhi does not cause disease in
nonprimate vertebrates or in lower primates (i.e., Rhesus ma-
caques). Although higher primates (i.e., chimpanzees) infected
with serotype Typhi develop a typhoid fever-like disease, the
scarcity of these animals has effectively prevented the use of
this model (7). The lack of a suitable animal model makes it
difficult to test whether phenotypes observed during the inter-
action of serotype Typhi with human cell lines in vitro are
representative of changes occurring during the interaction of
serotype Typhi with human tissue in vivo. Recently, an ex vivo
model using human colonic tissue explants has been adapted
for studying serotype Typhimurium interaction with human
tissue (8). Here, we used the human colonic tissue explant
model to determine the role of the Vi antigen during interac-
tion of serotype Typhi with the human intestinal mucosa ex
vivo. These data provided an important link between results
from in vitro experiments and clinical observations from ty-
phoid fever patients.
MATERIALS AND METHODS
Bacterial strains and culture conditions. Serotype Typhi strain Ty2 was ob-
tained from the American Type Culture Collection (ATCC 19430). A deletion of
the viaB region in Ty2 was constructed by allelic exchange. DNA regions flanking
the viaB locus were PCR amplified (primers are listed in Table 1) and cloned into
a suicide plasmid (pGP704). A kanamycin resistance cassette (KSAC) was cloned
between the two DNA regions and the resulting plasmid introduced into sero-
type Typhi strain Ty2 by conjugation. Deletion of the viaB region in the resulting
strain (STY2) was confirmed by Southern hybridization using a viaB-specific
DNA probe. A mutation in invA was introduced into the STY2 chromosome by
inserting a suicide vector (pGP704) carrying an internal fragment of the invA
gene (Table 1) by homologous recombination to give rise to STY4. A mutation
in fliC was introduced into the Ty2 chromosome by inserting a suicide vector
(pGP704) carrying an internal fragment of fliC (Table 1) by homologous recom-
bination to give rise to STY3. Unless indicated otherwise, all serotype Typhi
strains were cultured statically in SOB broth (20 g/liter Tryptone, 5 g/liter yeast
extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2) for optimal expression of the
Vi antigen. Strain IR715 is a fully virulent spontaneous nalidixic acid-resistant
derivative of serotype Typhimurium strain ATCC 14028. Mutations in fljB and
fliC have been described previously (30) and were introduced into the serotype
Typhimurium 14028 chromosome by P22 transduction, yielding strain EHW26.
A mutation in msbB has been described previously (15) and was introduced into
serotype Typhimurium strain 14028 by P22 transduction to yield strain RPW3.
All serotype Typhimurium strains were grown statically (for infection of colonic
explants, HEK293 cells, or THP-1 cells) or with aeration (for T84 invasion assay)
in Luria-Bertani broth.
Flow cytometry. Flow cytometry was performed as described previously (14).
DNA was labeled with propidium iodide and Vi antigen detected by labeling cells
with rabbit anti-Vi serum (1:250 dilution; BD) and goat anti-rabbit fluorescein
isothiocyanate (FITC) conjugate (1:250 dilution; Jackson ImmunoLabs). For
each sample, the fluorescence of 10,000 particles (bacterial cells) was measured
by flow cytometry (FACSCalibur; Becton Dickinson). A rectangular two-dimen-
sional selection region (bitmap) was drawn such that less than 2% of the control
population (serotype Typhimurium) was counted positive for the selected FITC
fluorescence intensity.
Human colonic tissue explant model. Colonic biopsies (six biopsies/patient)
were collected from patients (between 50 and 80 years of age) undergoing colon
cancer screening after we obtained their informed consent and approval from the
Institutional Review Boards of Texas A&M University and Scott & White Clinic.
Human colonic tissue explants were used as described previously (8) with the
following modification. Tissue explants were inserted into Snapwell plates (Corn-
ing-Costar) to generate a luminal and a serosal compartment as described pre-
viously (6). The luminal compartments of biopsy samples from each individual
patient were infected either with approximately 107 bacteria (serotype Typhi-
murium strain IR715, serotype Typhi strain Ty2, or serotype Typhi strain STY2)
or with sterile medium. Tissue was snap-frozen 8 h after infection. RNA was
extracted from snap-frozen tissue with 1 ml of Tri reagent (Molecular Research
Center) according to instructions by the manufacturer. Next, 500 ng of each
sample was retrotranscribed in a 50 l volume (Taqman reverse transcription
reagents; Applied Biosystems) and 4 l of cDNA was used for each real-time
(RT)-PCR. RT-PCR with primers (33) to detect human IL-8 (CXCL-8) and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was performed using
SYBR Green (Applied Biosystems) and the GeneAmp 5700 Sequence Detection
System. The data were analyzed using the comparative Ct method (Applied
Biosystem).
Infection of human cell lines. T84 cells were grown in Dulbecco’s modified
Eagle medium (DMEM)-F12 medium (Gibco), containing 1.2 g/liter sodium
bicarbonate, 2.5 mM L-glutamine, 15 mM HEPES, and 0.5 mM sodium pyruvate
(Gibco), supplemented with 10% fetal calf serum (FCS). To polarize T84 cells,
0.5 ml of medium containing 4  105 cells/well was seeded on the apical com-
partment in 12-mm Transwell plates (12-mm Transwell, polycarbonate mem-
brane, pore size of 0.4 micron; Corning-Costar) and 1.5 ml of medium was added
to the basolateral compartment. The medium was changed every other day, and
the transepithelial electrical resistance was measured after a week. When the
cells reached a transepithelial electrical resistance of at least 1500 cm2, they
were incubated overnight in fresh medium and an assay was performed the
following day. For analyzing changes in host gene expression, bacteria (1 
107/well) were added to the apical side of polarized T84 cells for 1 h and RNA
extracted for RT-PCR analysis as described above. For analyzing invasion, bac-
teria (1  107/well) were added to the apical side of polarized T84 cells for 1 h
and washed five times with Dulbecco’s phosphate-buffered saline 14040 (Gibco)
and medium containing 0.1 mg gentamicin/ml was added for 90 min. Intracellular
bacteria were quantified by spreading serial 10-fold dilutions of T84 cell lysates
(1% Triton X-100) on Luria-Bertani agar plates to determine the number of
CFU.
THP-1 cells seeded at approximately 5  105 cells/well in 24-well plates
containing RPMI 1640 plus 10% FCS were differentiated with 50 ng/ml phorbol
12-myristate 13-acetate (PMA) for 48 h followed by growth without PMA for 4
days. Cells were infected with 1  107 bacteria/well for 1 h, washed, and incu-
bated with 0.1 mg/ml gentamicin for 1 h. Subsequently, cells were incubated in
medium containing 0.025 mg/ml gentamicin for 4 h. Six hours after infection,
RNA extraction and RT-PCR analysis were performed as described above.
HEK293 cells stably transfected with human TLR4/MD2/CD14 or human
TLR5 were purchased from Invivogen. Cells were maintained in DMEM with
glucose (4.5 g/liter) and 10% FCS supplemented with blasticidin or hygromycin
according to the manufacturer’s instructions. Cells were seeded (5  105 cells/
well) in 24-well plates containing DMEM and 10% FCS and infected with 1 
107 bacteria/well for 4 h. To assess the response of HEK293 cells to purified
PAMPs, purified serotype Typhimurium flagella (1 g/ml) or S. enterica serotype
Minnesota lipopolysaccharide (LPS, 10 g/ml; Invivogen) was added and incu-
bated for 4 h. RNA extraction and RT-PCR analysis were performed as de-
scribed above.
Statistical analysis. For statistical analysis of ratios (i.e., fold increases in IL-8
expression or invasion data expressed as percentage of inoculum), data were
TABLE 1. Primers used in this study
Primer use Sequence (5 to 3)
PCR amplification
of upstream and
downstream
regions of viaB
TGGGTTAGCCAAAGAC
GTCGACTGATGTCAAACCTGCAC
GTCGACGTCACCATCAGTAGCACAACG
GCACGGACTGTTCCTTGCG
Amplification of
invA
GTGAAATTATCGCCACGTTCGGGCAA
TCATCGCACCGTCAAAGGAACC
Amplification of
serotype Typhi
CAGAACGAAGTGTATCAACCTGTGC
CCGAAAGAAACTGCTGTAACCG
fliC
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transformed logarithmically to calculate geometric means and for statistical
analysis. A parametric test (paired Student’s t test) was used to calculate whether
differences in fold increases of IL-8 expression or invasion between treatment
groups were statistically significant.
RESULTS
Deletion of the viaB region of serotype Typhi. To determine
whether the Vi antigen plays a role in preventing the produc-
tion of neutrophil chemoattractants during infection, we con-
structed a derivative of serotype Typhi strain Ty2 carrying a
precise deletion of the viaB region by allelic exchange (STY2)
(Fig. 1A). Unlike the serotype Typhi wild type (Ty2), the se-
rotype Typhi viaB mutant (STY2) could not be agglutinated
with anti-Vi antiserum (data not shown). Expression of the Vi
antigen in strains Ty2 and STY2 was further investigated by
flow cytometry. Cells were labeled with rabbit anti-Vi anti-
serum and goat anti-rabbit IgG FITC conjugate for detection
of the Vi antigen (y axes) and propidium iodide for detection
of DNA (x axes). The gate for detection of Vi expression was
set such that serotype Typhi cells were considered positive for
expressing the Vi antigen when their FITC fluorescence inten-
sity exceeded that of all but a small fraction (less than 2%) of
a Vi antigen negative control population (i.e., serotype Typhi-
murium cells). Using this gate, expression of the Vi antigen was
detected by flow cytometry in the serotype Typhi wild type
(Ty2) but not the serotype Typhi viaB mutant (STY3) (Fig.
1B).
The Vi antigen reduces IL-8 expression in human intestinal
epithelial cells. Interaction with the intestinal mucosa during
serotype Typhi and serotype Typhimurium infection is initi-
ated by invasion of the intestinal epithelium. Early mechanisms
by which the Vi antigen may diminish IL-8 production in the
intestinal mucosa were thus investigated using the polarized
epithelial cells derived from a human colonic carcinoma (T84
cells) as a model.
Serotype Typhimurium is a biphasic serotype in which a
phase variation mechanism results in the expression of flagella
that are composed of either flagellin protein FliC (H1 phase)
or FljB (H2 phase). Infection of polarized T84 cells with the
serotype Typhimurium wild type (IR715) resulted in an ap-
proximately sevenfold increase in IL-8 expression (P  0.05)
(Fig. 2A). Unlike the serotype Typhimurium wild type, a non-
flagellated serotype Typhimurium mutant (fliC fljB mutant)
did not elicit IL-8 expression in polarized T84 cells (Fig. 2A).
These findings were consistent with the previous observation
that IL-8 production in T84 cells is triggered by the recognition
of serotype Typhimurium flagella through TLR5 (36). A non-
invasive serotype Typhimurium strain (invA mutant) caused
levels of IL-8 expression similar to those of the isogenic wild
type (Fig. 2A), which was consistent with earlier reports that
bacterial invasion does not contribute to chemokine produc-
tion in polarized T84 cells (36).
Serotype Typhi is a monophasic serotype which encodes only
a single flagellin gene, fliC. Infection of polarized T84 cells
with the serotype Typhi wild type (Ty2) or a serotype Typhi fliC
mutant (STY3) resulted in only a modest (less that twofold)
increase in IL-8 expression (Fig. 2B). The serotype Typhi viaB
mutant (STY2) elicited significantly (P  0.05) higher IL-8
expression in T84 cells than the serotype Typhi wild type (Ty2)
or the fliC mutant (STY3) (Fig. 2B). Expression of the FliC
flagellin protein of serotype Typhi could be detected in the
wild type (Ty2) and the viaB mutant (STY2) by both slide
agglutination and Western blotting using anti-FliC antiserum,
suggesting that the expression of a capsule did not prevent the
expression of flagella (data not shown). Expression of the Vi
capsular antigen reduced the invasiveness of serotype Typhi
for polarized T84 cells, as shown by a gentamicin protection
assay (Fig. 2C). However, the ability to invade T84 cells did not
affect the IL-8 expression elicited by serotype Typhi because a
noninvasive, noncapsulated strain (viaB invA mutant strain
STY4) and an invasive noncapsulated strain (viaB mutant
strain STY2) both elicited similar levels of IL-8 expression
(Fig. 2B and C). Collectively, these data provided evidence that
induction in T84 cells of IL-8 expression could be significantly
reduced by expression of the Vi antigen.
The Vi antigen reduces IL-8 expression in human macro-
phage-like cells. Subsequent to penetration of the intestinal
epithelium, serotype Typhimurium is found exclusively intra-
cellularly in the lamina propria within mononuclear cells and
neutrophils (28). This interaction with phagocytes in the lam-
ina propria likely contributes to chemokine production in tis-
sue, since human macrophages produce IL-8 in response to
stimulation with serotype Typhimurium PAMPs, including
LPS (TLR4/MD-2/CD14 ligand) and flagella (TLR5 ligand) in
vitro (22, 23, 27). Late mechanisms by which the Vi antigen
may reduce IL-8 production in the human lamina propria were
thus investigated using human macrophage-like (THP-1) cells
as a model.
Infection with the serotype Typhimurium wild type (IR715)
induced the expression of IL-8 in THP-1 cells (Fig. 2D). This
response was significantly (P  0.05) reduced in THP-1 cells
infected with the serotype Typhi wild type (Ty2) or with a
serotype Typhimurium mutant expressing a form of LPS in
which acylation of lipid A is reduced, thereby preventing rec-
ognition through TLR4/MD2/CD14 (msbB mutant). In con-
trast, the serotype Typhi viaB mutant (STY2) elicited IL-8
production at levels similar to those of the serotype Typhi-
FIG. 1. Construction of a viaB deletion mutant of serotype Typhi
strain Ty2. (A) Schematic drawing of the DNA region deleted in the
serotype Typhi viaB mutant. A bracket indicates the size and location
of the deletion relative to the first nucleotide of the tviA open reading
frame. (B) Analysis of the serotype Typhi wild type (left panel) and the
serotype Typhi viaB mutant (right panel) for expression of the Vi
antigen (FITC fluorescence intensity, y axes) by flow cytometry. DNA
of bacterial cells was labeled with propidium iodide (x axes).
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murium wild type (IR715). Similar numbers of the serotype
Typhi wild type (Ty2) and the viaB mutant (STY2) were re-
covered from THP-1 cells at the time RNA was collected,
suggesting that differences in IL-8 production were not due to
differences in bacterial load (data not shown). Furthermore, a
significant (P  0.05) increase in IL-8 production elicited by
the serotype Typhi viaB mutant (STY2) compared to the wild
type (Ty2) was also observed when above experiment was re-
peated with formaldehyde-killed bacteria (data not shown).
These data provided evidence that expression of the Vi antigen
attenuates IL-8 production in THP-1 cells.
The Vi antigen reduces IL-8 expression induced by TLR
signaling. To directly test whether the expression of capsular
polysaccharide reduces TLR signaling by host cells, we mea-
sured IL-8 expression by human embryonic kidney (HEK293)
cells transfected with human TLR5 (HEK293-TLR5 cells) or
human TLR4/MD2/CD14 (HEK293-TLR4 cells) in response
to bacterial infection. Induction of IL-8 expression in untrans-
fected HEK293 cells infected with serotype Typhi (data no
shown) or commercially obtained purified serotype Typhi-
murium flagella (Fig. 3A) was negligible. IL-8 expression could
be induced in HEK293-TLR4 cells by adding purified LPS.
Purified serotype Typhimurium flagella also induced IL-8 ex-
pression in HEK293-TLR4 cells, presumably because the prep-
aration contained LPS contamination. Addition of purified
serotype Typhimurium flagella to HEK293-TLR5 cells induced
IL-8 expression, but addition of purified LPS did not (Fig. 3A).
These data confirmed that IL-8 production in HEK293-TLR5
cells is due to the recognition of flagella by TLR5 and in
HEK293-TLR4 cells to the recognition of LPS by the TLR4/
MD2/CD14 receptor complex.
Flagella did not contribute to the innate immune recognition
of serotype Typhi in HEK293-TLR4 cells because the wild type
and the fliC mutant elicited similar levels of IL-8 expression.
The noncapsulated serotype Typhi viaB mutant elicited signif-
icantly (P  0.05) higher levels of IL-8 expression in HEK293-
TLR4 cells than the capsulated serotype Typhi wild type (Fig.
3B), suggesting that the Vi antigen attenuates host responses
elicited through TLR4.
The serotype Typhi wild type (Ty2), but not the serotype
Typhi fliC mutant (STY3), elicited IL-8 expression in HEK293-
TLR5 cells (Fig. 3C), thus confirming the notion that IL-8
FIG. 2. Interaction of capsulated and noncapsulated bacteria with polarized human colonic epithelial (T84) cells and human macrophage-like
(THP-1) cells. (A) IL-8 expression induced by serotype Typhimurium in polarized T84 cells. (B) IL-8 expression induced by serotype Typhi in
polarized T84 cells. Bacteria (1  107/well) in panels A and B were added to the apical side of polarized T84 cells, and RNA was extracted 1 h
after infection. (C) Serotype Typhi invasion of polarized T84 cells. Bacteria (1  107/well) were added to the apical side of polarized T84 cells for
1 h, washed, and incubated in medium containing 0.1 mg gentamicin/ml for an additional 90 min before we determined the number of intracellular
bacteria. (D) IL-8 expression induced by serotype Typhi and serotype Typhimurium in THP-1 cells. Cells were infected with 1  107 bacteria/well
for 1 h, washed, and incubated with gentamicin for an additional 5 h prior to RNA extraction. All data are shown as geometric means from three
independent experiments  standard deviations.
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production in this cell line is due to the stimulation of TLR5 by
serotype Typhi flagella. The noncapsulated serotype Typhi
viaB mutant (STY2) elicited significantly (P  0.05) higher
levels of IL-8 expression in HEK293-TLR5 cells than the cap-
sulated serotype Typhi wild type (Ty2) (Fig. 3C). These results
provided evidence that IL-8 expression elicited by the recog-
nition of flagellin through TLR5 is attenuated by expression of
the Vi antigen in serotype Typhi.
Collectively, these data demonstrated that expression of the
Vi antigen diminishes a response (i.e., IL-8 expression) that is
induced in host cells when serotype Typhi PAMPs (i.e., flagella
and LPS) are recognized by their cognate pathogen recogni-
tion receptors (i.e., TLR5 and TLR4).
The Vi antigen prevents IL-8 expression in human colonic
tissue explants. Serotype Typhi is a strictly human-adapted
pathogen, causing disease only in humans and higher primates
(i.e., chimpanzees) (7). To investigate the role of the Vi anti-
gen in a relevant model that closely resembles host pathogen
interaction in vivo, we studied the infection of human colonic
tissue explants. Human colonic tissue explants were obtained
from patients undergoing colon cancer screening, sandwiched
between circular Plexiglas pieces containing a central hole, and
inserted into Costar Snapwell plates (Fig. 4A). Using samples
from one individual patient, the top (luminal) compartment of
each Snapwell plate was infected with either serotype Typhi-
murium, serotype Typhi, the serotype Typhi viaB mutant, or a
mock control (sterile medium). The experiment was repeated
with biopsy samples from three individual patients. Eight hours
after infection, RNA was extracted from tissue explants and
IL-8 expression quantified by RT-PCR.
While serotype Typhimurium elicited the expression of IL-8
in human colonic explants, serotype Typhi did not (Fig. 4B).
Deletion of the viaB region resulted in a significant increase in
IL-8 expression elicited by serotype Typhi (Fig. 4B). There was
variation in the level of IL-8 expression between samples from
different patients. However, IL-8 expression in samples from
each individual patient was increased after infection with the
serotype Typhimurium wild type and the serotype Typhi viaB
mutant, while in each case no increase (compared to the mock
FIG. 3. IL-8 expression elicited by serotype Typhi or purified
PAMPs in human embryonic kidney (HEK293) cells stably transfected
with human TLRs. (A) IL-8 expression induced by purified PAMPs in
HEK293 cells and HEK293 cells transfected with TLRs. Cells were
incubated for 4 h with purified serotype Typhimurium flagella (1 g/
ml) or serotype Minnesota LPS (10 g/ml) prior to RNA extraction.
(B) IL-8 expression induced by serotype Typhi in HEK293 cells trans-
fected with human TLR4/MD2/CD14. (C) IL-8 expression induced by
serotype Typhi in HEK293 cells transfected with human TLR5. Cells
in panels B and C were infected with 1 107 bacteria/well for 4 h prior
to RNA extraction. All data are shown as geometric means from three
independent experiments  standard deviation.
FIG. 4. IL-8 expression elicited by serotypes Typhi and Typhi-
murium in human colonic tissue explants. (A) Human colonic tissue
explant model. Tissue explants (e) were inserted into Snapwell plates
to generate luminal (a) and serosal (s) compartments. RNA was col-
lected 8 h after infection of the luminal compartment. (B) Fold in-
crease of IL-8 expression in human colonic tissue explants upon infec-
tion with capsulated or noncapsulated bacteria. Data are shown as
geometric means from three independent experiments  standard
deviations.
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infected control) in IL-8 expression was detected in tissue
infected with the serotype Typhi wild type. These data sug-
gested that mechanisms by which the Vi antigen reduces the
production of neutrophil chemoattractants in human tissue
culture cells in vitro abrogate IL-8 expression during infection
of the human intestinal mucosa.
DISCUSSION
Intestinal biopsy samples collected from humans infected
with serotype Typhimurium contain an inflammatory infiltrate
that is dominated by neutrophils (4, 19). In contrast, neutro-
phils are sparse or absent in intestinal biopsies from typhoid
fever patients (17, 32). Little progress has been made in un-
derstanding why serotype Typhimurium and serotype Typhi
cause different types of inflammatory infiltrates in the human
intestine, in part because higher primates (i.e., chimpanzees)
are the only animal model for studying infection with the
strictly human-adapted serotype Typhi. Dougan and coworkers
recently established a human colonic tissue explant model for
studying the interaction of serotype Typhimurium with the
intestinal mucosa (8). Here, we show that colonic tissue ex-
plants can be used to model the differences in the inflamma-
tory responses elicited by serotype Typhimurium and serotype
Typhi in the human intestine. That is, infection with serotype
Typhimurium induced expression of the neutrophil chemoat-
tractant IL-8 in human colonic explants, which correlated well
with the neutrophilic infiltrate observed in the intestinal biopsy
samples collected from patients infected with serotype Typhi-
murium (4, 19). Similarly, the absence of IL-8 expression in
human colonic explants infected with serotype Typhi corre-
lated well with the reported scarcity of neutrophils in intestinal
biopsy samples from typhoid fever patients (17, 32). In the
absence of a convenient animal model for studying the inter-
action of serotype Typhi with the intestinal mucosa, human
colonic tissue explants are a powerful and necessary tool for
verifying that data obtained using simplified models (i.e., in
vitro experiments with human cell lines) can be reproduced in
the complex environment of human tissue.
In vitro studies suggest that serotype Typhimurium causes a
neutrophil influx in the human intestinal mucosa because its
PAMPs (i.e., flagella and LPS) activate TLR signaling path-
ways in host cells (i.e., in epithelial cells and macrophages),
which results in the release of neutrophil chemoattractants
(e.g., IL-8 and GRO). Tissue culture models further suggest
that, during serotype Typhimurium infection, IL-8 expression
in the human intestinal mucosa is induced by a TLR5-medi-
ated response in the intestinal epithelium (36) and by a TLR4-
and TLR5-mediated response in macrophages of the lamina
propria (22, 23, 27). Events leading to diarrhea and neutrophil
infiltration in the intestines of patients infected with serotype
Typhimurium can be modeled in vivo using serotype Typhi-
murium infection of calves (29, 38). Analysis of GRO expres-
sion elicited by serotype Typhimurium in bovine ligated ileal
loops in situ shows that at 1 h after infection, epithelial cells are
the predominant cell type expressing this neutrophil chemoat-
tractant (37). At 1 h after infection of bovine ligated ileal loops,
the bulk of the bacteria is located either in the intestinal lumen
or within epithelial cells (26, 28). By 4 h after infection, sero-
type Typhimurium clears the bovine ileal epithelium and is
detected by electron microscopy within neutrophils and mono-
nuclear cells in the lamina propria (28). The in vitro and in vivo
observations described above imply that at later time points
after serotype Typhimurium infection (4 h), phagocytes in
the lamina propria may be a source of CXC chemokine pro-
duction. Our data show that the fold increase in IL-8 expres-
sion induced during the serotype Typhimurium infection of
macrophage-like cells in vitro (	300-fold) is far greater than
that elicited in human epithelial cells (approximately seven-
fold). However, further in situ analysis is required to determine
the relative contribution of epithelial cells and mononuclear
cells to chemokine production in the intestinal mucosa at later
times after infection with serotype Typhimurium.
Tissue culture experiments show that the release of IL-8 in
cultured epithelial cells or macrophages infected with serotype
Typhi is markedly decreased compared to that seen in re-
sponse to serotype Typhimurium infection (11, 18, 36). How-
ever, it is not obvious why serotype Typhi does not trigger the
release of IL-8 in the human intestinal mucosa, because sero-
type Typhi is an invasive pathogen and purified serotype Typhi
flagella or purified serotype Typhi LPS are potent inducers of
IL-8 secretion in human monocytes (1, 22, 35).
Here, we show that, compared to serotype Typhimurium,
serotype Typhi elicits reduced IL-8 expression in cultured ep-
ithelial cells (T84) and macrophages (THP-1) because it ex-
presses the Vi antigen. These data confirmed a recent report in
which capsulated and noncapsulated clinical isolates of sero-
type Typhi were compared in order to investigate the role of
the Vi antigen in modulating IL-8 expression in a human ep-
ithelial cell line (Caco-2) (31). Whole genome sequencing of
serotype Typhi strains Ty2 and CT18 illustrates that different
serotype Typhi clinical isolates exhibit marked genetic differ-
ences. For example, serotype Typhi Ty2 possesses 29 genes
that are absent from the serotype Typhi CT18 genome and
CT18 possessing 84 genes that are absent from the Ty2 genome
(5). Furthermore, 9 genes that are intact in Ty2 are pseudo-
genes in the CT18 genome while 11 genes that are intact in
CT18 are pseudogenes in the Ty2 genome (5). The presence of
numerous genetic differences makes it difficult to draw com-
pelling conclusions from a comparison between capsulated and
noncapsulated serotype Typhi clinical isolates. To directly test
whether expression of a capsular polysaccharide prevents the
production of neutrophil chemoattractants, we compared the
IL-8 expression elicited in human cell lines during infection
with a serotype Typhi wild-type isolate (Ty2) with that elicited
by its isogenic viaB deletion mutant (STY2). Our data show
that the Vi antigen is a serotype Typhi virulence factor that
reduces TLR5 and TLR4/MD2/CD14-mediated IL-8 expres-
sion in host cells. These data implied that, in the absence of the
Vi antigen, serotype Typhi PAMPs (i.e., flagella and LPS)
efficiently induce TLR-dependent IL-8 expression in host cells.
Unlike the serotype Typhi wild type (Ty2), a serotype Typhi
viaB mutant (STY2) was able to elicit IL-8 expression in hu-
man tissue culture cells at levels similar to those seen during
serotype Typhimurium infection. Similarly, the serotype Typhi-
murium wild type and the serotype Typhi viaB mutant elicited
IL-8 expression in human colonic tissue explants, while no IL-8
expression was elicited during infection with the capsulated
serotype Typhi wild type. These data demonstrate for the first
time that Vi antigen-mediated suppression of IL-8 production
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can be observed in a model (i.e., human tissue explants) that
closely resembles host pathogen interaction in vivo, thereby
providing support for the idea that the Vi antigen is responsi-
ble for the differences in inflammatory infiltrates elicited by
serotype Typhi and serotype Typhimurium in the human in-
testinal mucosa.
While this study was in progress, Sharma and Qadri showed
that purified Vi antigen binds to prohibitin at the surface of
intestinal epithelial cells (Caco-2 cells) (31). Furthermore, pu-
rified Vi antigen reduces extracellular signal-regulated kinase
phosphorylation and IL-8 production in response to the PMA
stimulation (TLR stimulation was not investigated in this
study) of Caco-2 cells (31). The Vi antigen-mediated inhibition
of the mitogen-activated protein kinase pathway described by
Sharma and Qadri is likely a mechanism contributing to the Vi
antigen-mediated inhibition of TLR signaling and IL-8 pro-
duction described in this study. A capsule-mediated inhibition
of TLR signaling provides an attractive explanation for the
scarcity of neutrophils in the intestinal infiltrates of typhoid
fever patients.
Our data suggest that a noncapsulated serotype Typhi strain
would show a greater propensity to elicit neutrophil infiltration
in the intestinal mucosa because its PAMPs (i.e., LPS and
flagella) would activate TLR signaling pathways in host cells.
However, a neutrophilic infiltrate is not noted during infection
of volunteers with a serotype Typhi galE viaB vaccine candi-
date (12, 13). A likely explanation for this finding is that a
strain carrying a mutation in galE, a gene encoding the enzyme
uridine-5-diphospate galactose epimerase required for the
biosynthesis of the LPS outer core, is not able to elicit neutro-
phil infiltration. The finding that a serotype Typhimurium galE
mutant is unable to elicit neutrophil influx and fluid accumu-
lation in bovine ligated ileal loops, an animal model for human
gastroenteritis, provides experimental support for this idea (2).
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